ID

4580

Descrizione

A Randomized, Open-label Study of the Effect of PEGASYS Combined With Ribavirin on Sustained Virologic Response in Patients With Chronic Hepatitis C Who Did Not Respond to Previous Pegintron/Ribavirin Combination Therapy Inclusion Criteria - adult patients >=18 years of age - CHC infection - liver biopsy (in <24 calendar months of first dose), with results consistent with CHC infection - use of 2 forms of contraception during study and 6 months after the study in both men and women - Lack of response to previous treatment with peginterferon alfa-2b (12KD)/ribavirin combination therapy given for >=12 weeks Exclusion Criteria - women who are pregnant or breastfeeding - male partners of women who are pregnant - conditions associated with decompensated liver disease - other forms of liver disease, including liver cancer - human immunodeficiency virus infection

Keywords

  1. 11/12/13 11/12/13 - Martin Dugas
Caricato su

11 dicembre 2013

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY-NC 3.0 Legacy

Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Eligibility NCT00087646 Hepatitis C

Eligibility

  1. StudyEvent: Eligibility
    1. Eligibility
Inclusion criteria
Descrizione

Inclusion criteria

adult patients >=18 years of age
Descrizione

Age

Tipo di dati

boolean

CHC infection
Descrizione

Chronic Hepatitis C

Tipo di dati

boolean

liver biopsy (in <24 calendar months of first dose), with results consistent with CHC infection
Descrizione

Liver biopsy

Tipo di dati

boolean

use of 2 forms of contraception during study and 6 months after the study in both men and women
Descrizione

Contraception men and women

Tipo di dati

boolean

Lack of response to previous treatment with peginterferon alfa-2b (12KD)/ribavirin combination therapy given for >=12 weeks
Descrizione

Previous medication

Tipo di dati

boolean

Exclusion criteria
Descrizione

Exclusion criteria

women who are pregnant or breastfeeding
Descrizione

Pregnancy / Lactation

Tipo di dati

boolean

male partners of women who are pregnant
Descrizione

Pregnant partners

Tipo di dati

boolean

conditions associated with decompensated liver disease
Descrizione

Decompensated liver disease

Tipo di dati

boolean

other forms of liver disease, including liver cancer
Descrizione

Other liver disease

Tipo di dati

boolean

human immunodeficiency virus infection
Descrizione

HIV

Tipo di dati

boolean

Medical Concepts
Descrizione

Medical Concepts

Age
Descrizione

Age

Tipo di dati

string

Alias
UMLS CUI
C0001779
SNOMED CT 2010_0731
102518004
Diagnosis
Descrizione

Diagnosis

Tipo di dati

string

Alias
UMLS CUI
C0011900
SNOMED CT 2010_0731
439401001
Chronic hepatitis C
Descrizione

CHC

Tipo di dati

string

Alias
UMLS CUI
C0524910
SNOMED CT 2010_0731
128302006
MedDRA 13.1
10008912
Diagnostic procedure
Descrizione

Diagnostic procedure

Tipo di dati

string

Alias
UMLS CUI
C0430022
SNOMED CT 2010_0731
103693007
MedDRA 13.1
10061816
Contraception
Descrizione

Contraception

Tipo di dati

string

Alias
UMLS CUI
C0700589
SNOMED CT 2010_0731
146680009
MedDRA 13.1
10010808
Medication
Descrizione

Pharmaceutical Preparations

Tipo di dati

string

Alias
UMLS CUI
C0013227
pregnant
Descrizione

pregnant

Tipo di dati

string

Alias
UMLS CUI
C0549206
MedDRA 13.1
10036586
Breast feeding
Descrizione

Lactation

Tipo di dati

string

Alias
UMLS CUI
C0006147
MedDRA 13.1
10006247
Advanced chronic liver disease
Descrizione

Advanced chronic liver disease

Tipo di dati

string

Alias
UMLS CUI
C0860197
MedDRA 13.1
10001422
HIV negative
Descrizione

HIV negative

Tipo di dati

string

Alias
UMLS CUI
C0481430
SNOMED CT 2010_0731
143223008
MedDRA 13.1
10020179

Similar models

Eligibility

  1. StudyEvent: Eligibility
    1. Eligibility
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
Inclusion criteria
Age
Item
adult patients >=18 years of age
boolean
Chronic Hepatitis C
Item
CHC infection
boolean
Liver biopsy
Item
liver biopsy (in <24 calendar months of first dose), with results consistent with CHC infection
boolean
Contraception men and women
Item
use of 2 forms of contraception during study and 6 months after the study in both men and women
boolean
Previous medication
Item
Lack of response to previous treatment with peginterferon alfa-2b (12KD)/ribavirin combination therapy given for >=12 weeks
boolean
Item Group
Exclusion criteria
Pregnancy / Lactation
Item
women who are pregnant or breastfeeding
boolean
Pregnant partners
Item
male partners of women who are pregnant
boolean
Decompensated liver disease
Item
conditions associated with decompensated liver disease
boolean
Other liver disease
Item
other forms of liver disease, including liver cancer
boolean
HIV
Item
human immunodeficiency virus infection
boolean
Item Group
Medical Concepts
Age
Item
Age
string
C0001779 (UMLS CUI)
102518004 (SNOMED CT 2010_0731)
Diagnosis
Item
Diagnosis
string
C0011900 (UMLS CUI)
439401001 (SNOMED CT 2010_0731)
CHC
Item
Chronic hepatitis C
string
C0524910 (UMLS CUI)
128302006 (SNOMED CT 2010_0731)
10008912 (MedDRA 13.1)
Diagnostic procedure
Item
Diagnostic procedure
string
C0430022 (UMLS CUI)
103693007 (SNOMED CT 2010_0731)
10061816 (MedDRA 13.1)
Contraception
Item
Contraception
string
C0700589 (UMLS CUI)
146680009 (SNOMED CT 2010_0731)
10010808 (MedDRA 13.1)
Pharmaceutical Preparations
Item
Medication
string
C0013227 (UMLS CUI)
pregnant
Item
pregnant
string
C0549206 (UMLS CUI)
10036586 (MedDRA 13.1)
Lactation
Item
Breast feeding
string
C0006147 (UMLS CUI)
10006247 (MedDRA 13.1)
Advanced chronic liver disease
Item
Advanced chronic liver disease
string
C0860197 (UMLS CUI)
10001422 (MedDRA 13.1)
HIV negative
Item
HIV negative
string
C0481430 (UMLS CUI)
143223008 (SNOMED CT 2010_0731)
10020179 (MedDRA 13.1)

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial